← FDA Drug Approvals (Drugs@FDA)
TRABECTEDIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NATCO PHARMA LTD · Approved 2022-08-10
Drug application
- FDA Application #
ANDA214837- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TRABECTEDIN
- Generic name
- Trabectedin
- Active ingredients
- TRABECTEDIN
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- None (Tentative Approval)
- Sponsor
- NATCO PHARMA LTD
- First approval
- 2022-08-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown